TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29317812

Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium (IND/GLY) 110/50 μg once daily for 4 weeks
Number of subjects: 88

Group type: COMPARATOR
Intervention: Tiotropium (18 μg) once daily for 4 weeks
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium (IND/GLY)
Number of subjects: 88
Study: 24893912

Group type: EXPERIMENTAL
Intervention: Thiocolchicine 4mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Verapamil 5mg
Number of subjects: 25
Study: 24662570

Group type: EXPERIMENTAL
Intervention: Aerobic training (18 sessions, 3 times per week, 50% to 60% of VO2 peak, 25-40 minutes per session)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Detraining
Number of subjects: 21
Study: 23177968

Group type: EXPERIMENTAL
Intervention: Neural encoding of momentary evidence during decision making, measured through electrical brain signals, specifically parietal delta oscillations (1-3 Hz).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lateralized beta-band power (10-30 Hz) overlying human motor cortex.
Number of subjects: 0
Study: 20726884

Group type: EXPERIMENTAL
Intervention: Visual stimulus presentation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immediate reach towards the target
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual response in arm muscles
Number of subjects: 0
Study: 18675765

Group type: EXPERIMENTAL
Intervention: Face-to-face medication consultation provided by a community pharmacy resident.
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract).
Number of subjects: 186
Study: 16438891

Group type: EXPERIMENTAL
Intervention: Breast conserving therapy (BCT)
Number of subjects: 4461

Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 4461
Study: 12494876

Group type: EXPERIMENTAL
Intervention: 50mg sildenafil + 5mg dihydro-ergotamine (DHE)
Number of subjects: 0
Study: 10713873

Group type: EXPERIMENTAL
Intervention: ropivacaine 0.75%
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: ropivacaine 1%
Number of subjects: 45

Group type: COMPARATOR
Intervention: bupivacaine 0.5%
Number of subjects: 45
Study: 7542929

Group type: EXPERIMENTAL
Intervention: Cervical cancer screening service (service)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Education (leaflet on Pap smears)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 517
Study: 2043493

Group type: EXPERIMENTAL
Intervention: High-dose metoclopramide (10 mg/kg iv. loading dose + 7 hours continuous infusion) + lorazepam (2.5 mg x 4 po)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Low-dose metoclopramide (70 mg) + lorazepam (2.5 mg x 2 po) + dehydrobenzperidol (5 mg x 2 im)
Number of subjects: 34
Study: 30626198

Group type: EXPERIMENTAL
Intervention: Alcohol and other drug (AOD) use
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Sexual behavior
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Mental and physical health
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Cultural practices
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Discrimination experiences
Number of subjects: 185
Study: 31786466

Group type: EXPERIMENTAL
Intervention: Apatinib (VEGFR2 inhibitor)
Number of subjects: 42
Study: 30535668

Group type: EXPERIMENTAL
Intervention: Steroid arm (methylprednisone)
Number of subjects: 7406

Group type: COMPARATOR
Intervention: Placebo arm
Number of subjects: 7406
Study: 29089468

Group type: EXPERIMENTAL
Intervention: HTK solution
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 25245572

Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei subsp. paracasei L. casei W8 (1010 cfu)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (placebo capsules)
Number of subjects: 64
Study: 23900469

Group type: EXPERIMENTAL
Intervention: Glucometer for SMBG
Number of subjects: 105

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 105
Study: 21853766

Group type: EXPERIMENTAL
Intervention: Colored filters
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no colored filters)
Number of subjects: 27
Study: 21095276

Group type: EXPERIMENTAL
Intervention: ADHERE patients
Number of subjects: 82074

Group type: COMPARATOR
Intervention: ADHERE hospitals
Number of subjects: 82074
Study: 17094103

Group type: EXPERIMENTAL
Intervention: Entacapone 100 mg
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Entacapone 200 mg
Number of subjects: 341

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341
Study: 15735185

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 600

Group type: COMPARATOR
Intervention: Gliclazide
Number of subjects: 600
Study: 12060504

Group type: EXPERIMENTAL
Intervention: 1% penciclovir cream
Number of subjects: 248

Group type: COMPARATOR
Intervention: 3% aciclovir cream
Number of subjects: 248
Study: 9857648

Group type: EXPERIMENTAL
Intervention: Chemotherapy (mitomycin, cisplatin, vinblastine)
Number of subjects: 30
Study: 7832135

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 2225705

Group type: EXPERIMENTAL
Intervention: Atenolol (50 to 100 mg once a day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Enalapril (2.5 to 40 mg once a day)
Number of subjects: 30
Study: 552658

Group type: EXPERIMENTAL
Intervention: 1 mg RG 033
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 2 mg RG 033
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study: 30666357

Group type: EXPERIMENTAL
Intervention: GI-irAEs (Any grade)
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: High-grade diarrhea
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Patients with GI-irAEs
Number of subjects: 346

Group type: COMPARATOR
Intervention: ECOG 2–3
Number of subjects: 346

Group type: COMPARATOR
Intervention: LDH ≥ 618 IU/L
Number of subjects: 346

Group type: COMPARATOR
Intervention: Stage M1c
Number of subjects: 346

Group type: COMPARATOR
Intervention: Immunosuppressive treatment
Number of subjects: 346
Study: 28394172

Group type: EXPERIMENTAL
Intervention: Shorter total wake time (TWT) before treatment session
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Shorter total wake time (TWT) after treatment session
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Shorter total sleep time (TST) before treatment session
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Shorter total sleep time (TST) after treatment session
Number of subjects: 188
Study: 25911605

Group type: EXPERIMENTAL
Intervention: Dyslipidemia
Number of subjects: 3178

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 3178

Group type: EXPERIMENTAL
Intervention: Hypercholesterolemia
Number of subjects: 3178

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 3178

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 3178

Group type: EXPERIMENTAL
Intervention: Order of risk factor accrual
Number of subjects: 3178
Study: 23430381

Group type: EXPERIMENTAL
Intervention: 1.5 L PEG‐electrolyte solution plus 15 mg of mosapride
Number of subjects: 252

Group type: COMPARATOR
Intervention: 2 L PEG‐electrolyte solution plus 15 mg of mosapride
Number of subjects: 252
Study: 21276584

Group type: EXPERIMENTAL
Intervention: Quiet Eye (QE) training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (technical instruction only)
Number of subjects: 16
Study: 20141094

Group type: EXPERIMENTAL
Intervention: Custom-made foot orthoses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prefabricated foot orthoses
Number of subjects: 0
Study: 16934044

Group type: EXPERIMENTAL
Intervention: 8-prenylnaringenin (8-PN) 750 mg
Number of subjects: 24
Study: 15195722

Group type: COMPARATOR
Intervention: Conventional cement (Fuji I, GC)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Resin modified GI luting cement (Rely X, 3M/ESPE)
Number of subjects: 209
Study: 11168705

Group type: EXPERIMENTAL
Intervention: Clinical supervision
Number of subjects: 211

Group type: COMPARATOR
Intervention: Unsupervized nurses
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Supervized nurses (junior grades)
Number of subjects: 211
Study: 9268276

Group type: EXPERIMENTAL
Intervention: Comprehensive structured individual assessment with specific safety recommendations
Number of subjects: 482
Study: 8328683

Group type: EXPERIMENTAL
Intervention: Ifenprodil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3573654

Group type: EXPERIMENTAL
Intervention: pindolol 1%
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: timolol 0.5%
Number of subjects: 19
Study: 29309023

Group type: EXPERIMENTAL
Intervention: FM + CCS
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: FM + AT + CCS
Number of subjects: 99

Group type: COMPARATOR
Intervention: AT + CCS
Number of subjects: 99

Group type: COMPARATOR
Intervention: CCS
Number of subjects: 99
Study: 27045280

Group type: EXPERIMENTAL
Intervention: Low-level laser (100mW, 830nm)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (30U first session, 15U after 15 days)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Low-level laser and Botulinum toxin type A
Number of subjects: 15
Study: 24899217

Group type: EXPERIMENTAL
Intervention: Intensive workshop on evidence-based management of seasonal allergic rhinitis
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 246
Study: 21839654

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty (PTA) in addition to medical therapy (immediate treatment group - ITG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA) after 6 months of medical therapy alone (delayed treatment group - DTG)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI) results in immediate treatment group (ITG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Magnetic resonance imaging (MRI) results in delayed treatment group (DTG)
Number of subjects: 15
Study: 19717488

Group type: COMPARATOR
Intervention: Skeletal muscle OB-R170 protein expression in obese men
Number of subjects: 20

Group type: COMPARATOR
Intervention: SOCS3 protein expression in obese subjects
Number of subjects: 20

Group type: COMPARATOR
Intervention: Basal STAT3, AMPKalpha and ACCbeta phosphorylation levels in obese subjects
Number of subjects: 20
Study: 18656045

Group type: EXPERIMENTAL
Intervention: Cognitive training method
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard training method
Number of subjects: 30
Study: 16264053

Group type: EXPERIMENTAL
Intervention: CPAP therapy (Continuous Positive Airway Pressure)
Number of subjects: 31
Study: 12135820

Group type: EXPERIMENTAL
Intervention: Group support program
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Home visit program
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 187

Group type: COMPARATOR
Intervention: Group support program vs Control group
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Home visit program vs Group support program
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Younger female caregivers
Number of subjects: 187
Study: 10198952

Group type: EXPERIMENTAL
Intervention: Plain-clothes (PC) group
Number of subjects: 57

Group type: COMPARATOR
Intervention: Hospital gown (HG) group
Number of subjects: 57
Study: 7826293

Group type: EXPERIMENTAL
Intervention: Intensive treatment (insulin administration at least three times a day, adjusted based on self-blood glucose monitoring, aiming for normoglycemia)
Number of subjects: 1441

Group type: COMPARATOR
Intervention: Conventional treatment (one or two daily insulin injections)
Number of subjects: 1441

Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 1441
Study: 2136063

Group type: EXPERIMENTAL
Intervention: Transdermal clonidine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 305522

Group type: EXPERIMENTAL
Intervention: 600 mg Biarison
Number of subjects: 12

Group type: COMPARATOR
Intervention: 100 mg indometacin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: 900 mg Biarison (under double blind conditions)
Number of subjects: 12
Study: 31874153

Group type: EXPERIMENTAL
Intervention: Telenursing
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Face-to-face training
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (regular care)
Number of subjects: 90
Study: 30055303

Group type: EXPERIMENTAL
Intervention: DNS-7801 solutions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of citrate buffer at pH 3.0 and hydroxypropylbetadex
Number of subjects: 0
Study: 27385940

Group type: COMPARATOR
Intervention: CSE alone
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: CSE with lumbar plexus block (LPB)
Number of subjects: 92
Study: 24676950

Group type: EXPERIMENTAL
Intervention: Clinical scenario-based simulation education for communication
Number of subjects: 122

Group type: COMPARATOR
Intervention: Traditional class-based education for communication
Number of subjects: 122
Study: 22425235

Group type: EXPERIMENTAL
Intervention: Exercise training (8 weeks of gym-based aerobic and strengthening exercises, 3 times a week)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (mobilization alone)
Number of subjects: 14
Study: 20389223

Group type: EXPERIMENTAL
Intervention: Interview based on the theory of culture care by a nurse before visiting a gastroenterologist (Intervention group)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard medical examination by a gastroenterologist (Control group)
Number of subjects: 39
Study: 18402630

Group type: EXPERIMENTAL
Intervention: Lamotrigine treatment for 8 weeks
Number of subjects: 8
Study: 15836938

Group type: EXPERIMENTAL
Intervention: Harmonic analysis of force platform data in children with cerebral palsy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Harmonic analysis of force platform data in normal children (control group)
Number of subjects: 0
Study: 12115152

Group type: EXPERIMENTAL
Intervention: Numerical Rating Scale (NRS)
Number of subjects: 536

Group type: COMPARATOR
Intervention: Visual Analog Scale (VAS) and Likert scale
Number of subjects: 536
Study: 10862536

Group type: COMPARATOR
Intervention: FIO2: 0.21 (room air breathing)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: FIO2: 0.26 (increased FIO2)
Number of subjects: 25
Study: 8884760

Group type: EXPERIMENTAL
Intervention: alprazolam
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: bromazepam
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 1993795

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 6652271

Group type: EXPERIMENTAL
Intervention: Face-mask during sleep
Number of subjects: 20
Study: 30518246

Group type: EXPERIMENTAL
Intervention: BE-ACTIV intervention
Number of subjects: 41
Study: 27809558

Group type: EXPERIMENTAL
Intervention: Hatha yoga intervention (8 weeks)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Stretching control group (8 weeks)
Number of subjects: 118
Study: 25564724

Group type: EXPERIMENTAL
Intervention: Twins
Number of subjects: 1970

Group type: EXPERIMENTAL
Intervention: African-Americans
Number of subjects: 1970

Group type: EXPERIMENTAL
Intervention: Increasing gestational age at membrane rupture
Number of subjects: 1970
Study: 24796044

Group type: EXPERIMENTAL
Intervention: Jingjin acupuncture treatment (including acupuncture on palm side of affected hand, dorsal metacarpophalangeal joints, and proximal interphalangeal joints, once every other day, with electroacupuncture when qi was acquired)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Regular acupuncture (Shuigou (GV 26), Baihui (GV 20), Neiguan (PC 6), etc.)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Jingjin acupuncture treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Regular acupuncture
Number of subjects: 50
Study: 22892393

Group type: EXPERIMENTAL
Intervention: trastuzumab
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: lapatinib
Number of subjects: 210
Study: 20384388

Group type: EXPERIMENTAL
Intervention: DRSP 3 mg/EE 30 microg
Number of subjects: 0

Group type: COMPARATOR
Intervention: LNG 150 microg/EE 30 microg
Number of subjects: 0
Study: 18821656

Group type: EXPERIMENTAL
Intervention: Aerobics
Number of subjects: 30

Group type: COMPARATOR
Intervention: Qigong
Number of subjects: 30
Study: 15956121

Group type: COMPARATOR
Intervention: Ischemic exercise training (ET) for 4 weeks in patients with PAOD
Number of subjects: 3

Group type: COMPARATOR
Intervention: Nonischemic exercise training (ET) for 4 weeks in successfully revascularized patients with PAOD
Number of subjects: 3

Group type: COMPARATOR
Intervention: Subischemic exercise training (ET) for 4 weeks in patients with stable coronary artery disease
Number of subjects: 3
Study: 12427152

Group type: EXPERIMENTAL
Intervention: Oral l‐folinic acid at 20 mg/day
Number of subjects: 48

Group type: COMPARATOR
Intervention: Oral folic acid at 15 mg/day
Number of subjects: 48
Study: 10048736

Group type: EXPERIMENTAL
Intervention: H- II and FS (Flexible Sigmoidoscopy)
Number of subjects: 10978

Group type: COMPARATOR
Intervention: H- II alone
Number of subjects: 10978
Study: 7793558

Group type: EXPERIMENTAL
Intervention: Intravenous lignocaine 1.5 mg.kg‐1
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sodium chloride 0.9% (Control)
Number of subjects: 80
Study: 1941800

Group type: EXPERIMENTAL
Intervention: Cervex-Brush
Number of subjects: 1136

Group type: EXPERIMENTAL
Intervention: Cytobrush plus spatula
Number of subjects: 1136

Group type: COMPARATOR
Intervention: Control method (Ayre spatula with cotton swab or alone)
Number of subjects: 1136
Study: 6193472

Group type: EXPERIMENTAL
Intervention: cis‐DDP and bleomycin (arm A)
Number of subjects: 52

Group type: COMPARATOR
Intervention: methotrexate and vindesine (arm B)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: crossover from B to A
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: patients resistant to B treated with A
Number of subjects: 52
Study: 31802570

Group type: EXPERIMENTAL
Intervention: ENTREN-F programme (family intervention)
Number of subjects: 70

Group type: COMPARATOR
Intervention: ENTREN programme (psychological intervention for children)
Number of subjects: 70
Study: 30033514

Group type: EXPERIMENTAL
Intervention: Spirulina supplement (2 g/day) plus conventional regimen (220 mg/day zinc sulfate, 500 mg/day L-carnitine, and 50 mg/day clomiphene)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo plus conventional therapy
Number of subjects: 40
Study: 29924797

Group type: EXPERIMENTAL
Intervention: Outpatient Therapeutic Program (OTP) for SAM
Number of subjects: 494
Study: 26956541

Group type: EXPERIMENTAL
Intervention: Acupuncture (10 treatments over 8 weeks)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (7 sessions over 8 weeks)
Number of subjects: 160
Study: 25164487

Group type: EXPERIMENTAL
Intervention: Muffins made with sunflower oil (SFO)
Number of subjects: 20
Study: 18457100

Group type: EXPERIMENTAL
Intervention: Combined spinal‐epidural and general anesthesia (CSEGA)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Combined spinal and general anesthesia (CSGA)
Number of subjects: 16
Study: 15355149

Group type: EXPERIMENTAL
Intervention: New syntactic construction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experience with the novel construction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel construction
Number of subjects: 0
Study: 11003072

Group type: EXPERIMENTAL
Intervention: Commercially available metal detector
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard confirmatory radiographic imaging
Number of subjects: 10
Study: 9481274

Group type: EXPERIMENTAL
Intervention: Changing vascular equipment every 72 hours
Number of subjects: 211

Group type: COMPARATOR
Intervention: Changing vascular equipment every 48 hours (Control Group)
Number of subjects: 211
Study: 8493299

Group type: EXPERIMENTAL
Intervention: Testosterone (T)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Gonadotropin (Gn)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 9
Study: 3327710

Group type: EXPERIMENTAL
Intervention: Methylcellulose (25 eyes)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (22 eyes)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Air (19 eyes)
Number of subjects: 66
Study: 30702452

Group type: EXPERIMENTAL
Intervention: Pharmacist home visit and subsequent anticoagulation expert consultation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 31538569

Group type: EXPERIMENTAL
Intervention: iuMRI
Number of subjects: 570

Group type: COMPARATOR
Intervention: Ultrasonography
Number of subjects: 570
Study: 28744667

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus folinic acid, 5‐fluorouracil, and irinotecan (FOLFIRI)
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Ramucirumab
Number of subjects: 906

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 906
Study: 27498449

Group type: EXPERIMENTAL
Intervention: Warm air mattress (W)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 30
Study: 24132248

Group type: EXPERIMENTAL
Intervention: Galantamine (up to 24 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 22045595

Group type: EXPERIMENTAL
Intervention: TAS-108 40 mg daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TAS-108 80 mg daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TAS-108 120 mg daily
Number of subjects: 60
Study: 19308365

Group type: EXPERIMENTAL
Intervention: C/P (60 mg codeine + 1000 mg paracetamol) four times daily
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: L+C/P (levomepromazine 5 + 5 + 5 + 10 mg + C/P) four times daily
Number of subjects: 29
Study: 17259517

Group type: EXPERIMENTAL
Intervention: Thiazolidinediones (TZDs) therapy
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: TZDs in patients with diabetes
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: TZDs in patients without diabetes
Number of subjects: 608

Group type: COMPARATOR
Intervention: Standards of care
Number of subjects: 608